Company intelligence / Profile preview
CofixRX
- Ownership
- Private
- Development stage
- Other
Overview
CofixRX is a healthcare company that specializes in the development and distribution of pathogen-reducing nasal and throat sprays. The company's flagship product is a Povidone-Iodine-based nasal spray designed to provide an extra layer of protection against viruses and bacteria by neutralizing them in the nasopharynx. Developed by a team of board-certified physicians, CofixRX products are marketed as a preventative measure for individuals in high-risk environments or during peak viral seasons. The company leverages the well-established antiseptic properties of Povidone-Iodine to offer a non-prescription defense mechanism for respiratory health.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Small moleculeDevice
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on CofixRX.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CofixRX.